![Bertrand C. Liang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bertrand C. Liang
Direttore Tecnico/Scientifico/R&S presso PURPLE BIOTECH LTD
Posizioni attive di Bertrand C. Liang
Società | Posizione | Inizio | Fine |
---|---|---|---|
PURPLE BIOTECH LTD | Direttore Tecnico/Scientifico/R&S | 09/01/2020 | - |
Pico Pharmaceuticals, Inc. | Direttore/Membro del Consiglio | 08/12/2009 | - |
Asphelia Pharmaceuticals, Inc. | Direttore/Membro del Consiglio | 08/12/2009 | - |
Corporate Officer/Principal | - | 08/12/2009 | |
LCC Ventures | Direttore/Membro del Consiglio | 08/12/2009 | - |
Corporate Officer/Principal | - | - | |
Balboa Biosciences, Inc.
![]() Balboa Biosciences, Inc. BiotechnologyHealth Technology Balboa Biosciences, Inc. operates as a biopharmaceutical company. It develops therapeutics for central nervous system disorders. The company is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Bertrand C. Liang
Precedenti posizioni note di Bertrand C. Liang
Società | Posizione | Inizio | Fine |
---|---|---|---|
PFENEX INC. | Direttore/Membro del Consiglio | 30/12/2010 | 23/01/2017 |
Amministratore Delegato | 08/12/2009 | 23/01/2017 | |
Fondatore | 01/12/2009 | 23/01/2017 | |
Presidente | 01/12/2009 | 23/01/2017 | |
Segretario Aziendale | 01/12/2009 | 23/01/2017 | |
LA JOLLA PHARMACEUTICAL COMPANY | Direttore/Membro del Consiglio | 08/12/2010 | 19/01/2012 |
Paramount BioCapital Asset Management, Inc.
![]() Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | Gestore di Portafoglio-Azioni | - | 30/04/2007 |
University of Vermont | Corporate Officer/Principal | - | - |
░░░ ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Bertrand C. Liang
Regis University | Masters Business Admin |
The University of Bolton | Doctorate Degree |
Boston University | Undergraduate Degree |
Feinberg School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 20 |
Israele | 3 |
Giappone | 2 |
Posizioni
Director/Board Member | 10 |
Corporate Officer/Principal | 9 |
Founder | 3 |
Settori
Health Technology | 11 |
Consumer Services | 7 |
Finance | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 6 |
---|---|
TRACON PHARMACEUTICALS, INC. | Health Technology |
AMGEN INC. | Health Technology |
IDEC CORPORATION | Electronic Technology |
BIOGEN INC. | Health Technology |
FORTRESS BIOTECH, INC. | Health Technology |
PURPLE BIOTECH LTD | Health Technology |
Aziende private | 11 |
---|---|
Paramount BioSciences LLC
![]() Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
TRF Pharma, Inc.
![]() TRF Pharma, Inc. Pharmaceuticals: MajorHealth Technology TRF Pharma, Inc. develops pharmaceutical products. It specializes in the fields of hematology and oncology. The firm's services include developing therapies to treat diseases related to aberrant cell adhesion and endothelial walls. The company was founded by Stephen H. Embury and Neil Matsui in 2002 and is headquartered in Burlingame, CA. | Health Technology |
Balboa Biosciences, Inc.
![]() Balboa Biosciences, Inc. BiotechnologyHealth Technology Balboa Biosciences, Inc. operates as a biopharmaceutical company. It develops therapeutics for central nervous system disorders. The company is headquartered in San Diego, CA. | Health Technology |
Biogen MA, Inc.
![]() Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
National Cancer Institute
![]() National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Paramount BioCapital Asset Management, Inc.
![]() Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | Finance |
Pelican Inc
![]() Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
LCC Ventures | |
Asphelia Pharmaceuticals, Inc. | |
Pico Pharmaceuticals, Inc. | |
La Jolla Pharmaceutical Co.
![]() La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Bertrand C. Liang
- Esperienza